Lyme & Complex Chronic Illness
Evidence-informed integrative protocols for tick-borne illness, post-infectious syndromes, and multi-system conditions that persist beyond standard treatment.
Beyond Standard Treatment
Lyme disease and associated tick-borne infections often present far more complex clinical pictures than the acute textbook case. Patients with persistent or post-treatment Lyme syndrome frequently experience neurological, immunological, musculoskeletal, and metabolic symptoms that extend well beyond the initial infection.
BioReset approaches these conditions from a biological systems perspective — addressing immune dysregulation, mitochondrial compromise, toxin burden, and microbiome disruption that frequently accompany and perpetuate chronic tick-borne illness.
Conditions Addressed
The BioReset Approach to Lyme
Immune Rebalancing
Modulating the Th1/Th2/Th17 immune axis that drives persistent inflammation in chronic tick-borne disease.
Mitochondrial Support
Restoring cellular energy production commonly compromised by intracellular infection and oxidative stress.
Detoxification Enhancement
Supporting biotransformation pathways overwhelmed by infection byproducts and treatment side effects.
Microbiome Repair
Rebuilding gut ecology disrupted by prolonged antibiotic exposure and infection itself.
Ozone Immunomodulation
Medical ozone to stimulate immune competence and improve tissue oxygenation in affected systems.
What is Borreliosis?
Borreliosis, commonly known as Lyme disease, is a multisystem infectious disease caused primarily by the spirochete bacterium Borrelia burgdorferi and transmitted through the bite of infected ticks of the genus Ixodes.
These ticks are the primary vectors in Europe, North America, and Asia. When an infected tick attaches and feeds, the spirochete bacteria can enter the human bloodstream and migrate to multiple organ systems — including the skin, joints, heart, and nervous system.
Understanding the vector is essential: recognizing the Ixodes tick helps with prevention, early detection, and informs the clinical urgency of testing and treatment.
Symptoms & Disease Stages
Lyme disease progresses through distinct clinical stages. Recognizing early signs is critical for effective intervention — delayed diagnosis often leads to persistent, multi-system illness.
Erythema Migrans
The hallmark sign of early Lyme disease is erythema migrans — an expanding red rash that often resembles a bull's-eye or target pattern. It typically appears 3 to 30 days after the infected tick bite and expands gradually, reaching up to 30 cm in diameter.
Not all rashes present the classic bull's-eye. Some are uniformly red, raised, or bruise-like. The rash is usually warm to the touch but rarely itchy or painful.
Stage 1 — Early Localized
Days to 4 weeks after tick biteRash appears at bite site in 70-80% of cases. Early treatment yields highest cure rates.
Lyme Disease Progression Timeline
Infection
Tick bite
Borrelia burgdorferi enters bloodstream through infected Ixodes tick saliva during feeding.
Early Manifestation
3-30 days
Erythema migrans rash appears. Flu-like symptoms emerge. Highest treatment response window.
Dissemination
Weeks to years
Bacteria spread to joints, heart, CNS. Multi-system symptoms develop without intervention.
Lyme Recovery Stories
Real patient experiences from evidence-informed integrative Lyme protocols at BioReset. Outcomes reflect multi-system biological restoration.
“I had seen six specialists before finding BioReset. Dr. Milios identified co-infections and mitochondrial damage that had been completely missed. Within four months, my neurological symptoms had improved dramatically.”
J.P., 41
Lyme + Co-Infection Protocol — 4 months
“Post-treatment Lyme syndrome left me bedridden for two years. The integrative approach at BioReset — immune modulation, ozone, and mitochondrial support — gave me my life back when conventional medicine had given up.”
E.L., 36
Post-Treatment Lyme Protocol — 8 months
“The tick-borne panel here found Babesia and Bartonella alongside Lyme. Treating all three together, not just the Borrelia, was the key. For the first time in five years, I can work full-time again.”
D.M., 44
Multi-Pathogen Protocol — 6 months
“I had seen six specialists before finding BioReset. Dr. Milios identified co-infections and mitochondrial damage that had been completely missed. Within four months, my neurological symptoms had improved dramatically.”
J.P., 41
Lyme + Co-Infection Protocol — 4 months
Biological Markers: Before & After
Objective laboratory and clinical data from patients completing the BioReset Lyme Restoration Protocol. These are documented biological transformations, not anecdotes.
CD57+ NK Cell Count
Before
Below 60 cells/μL
After
185 cells/μL
Natural killer cell marker correlated with Lyme disease activity
Borrelia IgG / IgM Titers
Before
High positive bands
After
Seronegative / Remission
Western Blot + ELISA antibody profile
Inflammatory Cytokines
Before
IL-6: 28 pg/mL, TNF-α: 4.2 pg/mL
After
IL-6: 6 pg/mL, TNF-α: 1.1 pg/mL
Chronic inflammation marker panel
Mitochondrial ATP Output
Before
34% of age-matched optimal
After
71% of age-matched optimal
Cellular energy production (lymphocyte ATP assay)
Biotoxin / Mycotoxin Load
Before
Elevated Ochratoxin A, Aflatoxin
After
Below detection threshold
Great Plains Mycotox urine panel
Overall Symptom Severity
Before
8.4 / 10 (severe)
After
2.1 / 10 (mild)
General Symptom Questionnaire-30 (GSQ-30)
Lyme Disease FAQ
Evidence-informed answers about diagnosis, treatment duration, co-infections, and expected outcomes from Lyme protocols at BioReset.
We use a multi-layered diagnostic approach combining clinical evaluation with advanced laboratory testing. This includes standard two-tier ELISA / Western Blot testing, alongside specialized panels from ArminLabs (Borrelia EliSpot, CD57+ NK cell count), and co-infection screening for Babesia, Bartonella, Ehrlichia, and Anaplasma. We also assess mitochondrial function, inflammatory cytokines, and biotoxin burden to understand the full biological landscape. Clinical history and symptom patterns carry significant diagnostic weight, as no single test is 100% definitive.
Acute Lyme disease occurs within days to weeks of infection and typically responds well to short-course antibiotic therapy when treated early. Persistent or chronic Lyme disease — also called post-treatment Lyme disease syndrome (PTLDS) — involves symptoms that continue for months or years despite standard treatment. At BioReset, we address persistent Lyme by identifying co-infections, immune dysregulation, mitochondrial damage, toxin burden, and microbiome disruption that perpetuate symptoms beyond the initial infection.
Ixodes ticks can transmit multiple pathogens simultaneously. The most common co-infections we detect are Babesiosis (a malaria-like parasite affecting red blood cells), Bartonellosis (causing vascular and neurological symptoms), and Ehrlichiosis / Anaplasmosis (intracellular bacterial infections). Each co-infection requires distinct treatment, and missing them is a leading cause of persistent symptoms. BioReset protocols test and address all detectable co-infections alongside Borrelia.
Treatment duration varies significantly based on disease stage, duration of illness, co-infection burden, and individual biological response. Acute cases may resolve in 4–8 weeks. Persistent or chronic cases typically require 6–12 months of structured, phased treatment — starting with immune modulation and pathogen targeting, followed by mitochondrial restoration, detoxification, and microbiome repair. Patients with heavy co-infection or biotoxin burden may require longer protocols.
Medical ozone is one of our key immunomodulatory tools for chronic Lyme. Ozone major autohemotherapy (MAH) and ozonated saline IVs stimulate immune competence, improve tissue oxygenation, and support the oxidative killing of spirochete bacteria. Ozone also enhances mitochondrial function and reduces systemic inflammation. When combined with antimicrobial protocols, detoxification, and cellular support, ozone significantly accelerates recovery in our Lyme patient population.
The concept of 'cure' depends on disease stage and individual biology. Early Lyme treated promptly has an excellent prognosis. Chronic or persistent Lyme is better understood as a condition of biological restoration — restoring immune balance, mitochondrial energy, detoxification capacity, and microbiome health to a state where symptoms are absent and biological markers normalize. Many of our patients achieve sustained remission with comprehensive, multi-system protocols, though maintenance support is sometimes recommended for complex cases.
Complex Chronic Illness Consultation
If you are struggling with persistent symptoms after tick-borne illness, or suspect an undiagnosed infectious driver of your chronic condition, we can help map the biological landscape and design a restoration protocol.